MEDICINAL COMPOSITION WITH IMMUNOMODULATING EFFECT CONTAINING PEPTIDES AND ACCESSORY AGENTS Russian patent published in 2003 - IPC

Abstract RU 2219942 C2

FIELD: medicine, peptides, pharmacy. SUBSTANCE: invention relates to a medicinal composition containing at least one peptide with immunomodulating effect or protein (fragment) in combination with an accessory agent. Peptide is isolated from pathogen or antigen raised against tumor. Accessory agent shows property to enhance degree of peptide binding with cells of body, patient to be treated or to enhance peptide absorption by cells and to intensify immunomodulating effect of peptide also. Preferable accessory agents are basic amino acids, such as polyarginine or polylysine that if necessary can be coupled with cellular ligand, for example, with carbohydrate group or transferring. The composition is used, in particular, as vaccine, for example, as vaccine against tumor. Invention provides creating vaccine with immunomodulating effect. EFFECT: valuable medicinal properties of composition. 26 cl, 1 tbl, 18 dwg, 12 ex

Similar patents RU2219942C2

Title Year Author Number
IMMUNOSTIMULATOR INDUCING TUMOR-SPECIFIC IMMUNE CELLULAR RESPONSE AND METHOD FOR ITS PREPARING 1996
  • Shmidt Val'Ter
  • Birnshtil' Maks
  • Shvajgkhoffer Tamash
  • Shtajnljajn Peter
  • Bushle Mikhaehl'
RU2206329C2
METHOD AND PREPARATION FOR TREATING THE CASES OF FLAT CELL CANCER 1996
  • Khajder Karl-Khajnts
  • Adol'F Gjunter
  • Ostermann Ehlinborg
  • Pattsel'T Ehrik
  • Shproll' Marlis
RU2193779C2
ISOLATED NUCLEIC ACID ENCODING POLYPEPTIDE TAG 7, ISOLATED POLYPEPTIDE TAG 7, METHOD FOR INHIBITION OF TUMOR DEVELOPMENT IN MAMMALS (VARIANTS) AND METHOD FOR TREATMENT OF CANCER IN ANIMAL (VARIANTS) 1998
  • Georgiev Georgij
  • Kiselev Sergej
  • Prokhorchuk Egor
  • Ostermann Ehlinborg
RU2238976C2
ANTIBODY VFF-18 AND ITS ANALOGUES 1995
  • Adol'F Gjunter R.
  • Pattsel'T Ehrik
RU2204606C2
INDIVIDUALISED VACCINES FOR CANCER 2012
  • Sakhin Ugur
  • Krajter Sebastyan
  • Diken Mustafa
  • Dikmann Yan
  • Kozlovski Mikhael
  • Britten Tsedrik
  • Kestl Dzhon
  • Lever Martin
  • Renard Bernkhard
  • Omokoko Tana
  • De Graf Jokhannes Khendrikus
RU2670745C9
METHOD OF TREATING CANCER CARRYING EGFR MUTATIONS 2007
  • Zol'Ka Flavio
RU2492864C2
Bcl-2 PROTEINS, FRAGMENTS THEREOF, AND APPLICATION THEREOF IN PATIENTS WITH MALIGNANT TUMOUR 2004
  • Straten Ehjvind Per Tor
  • Andersen Mads Khal'D
RU2367468C2
METHOD OF THROMBOSIS TREATMENT OR PREVENTION WITH APPLICATION OF DABIGATRAN ETEXILATE OR ITS SALT WITH IMPROVED EFFICIENCY IN COMPARISON WITH STANDARD TREATMENT WITH WARFARIN 2009
  • Pol A. Rejlli
RU2530645C2
TUMOUR VACCINE CONTAINING ALLOGENIC OR XENOGENIC TUMOUR CELLS 2007
  • Statopoulos Apostolos
RU2456997C2
PREDICTION OF IMMUNOGENICITY OF T-CELL EPITOPES 2014
  • Sakhin Ugur
  • Tadmor Arbel David
  • Kasl Dzhon Kristofer
  • Begel Sebastyan
  • Lever Martin
RU2724370C2

RU 2 219 942 C2

Authors

Shmidt Val'Ter

Birnshtil' Maks

Shtajnljajn Peter

Bushle Mikhaehl'

Shvajgkhoffer Tamash

Dates

2003-12-27Published

1997-02-21Filed